已发表论文

基于全基因组测序的广州 B 族链球菌分离株血清型分布、抗生素耐药特征及毒力因子分析

 

Authors Ling Y , Deng Y , Zhang P, Yuan K , Ye L , Zhang X, Chen X, Cui S, Liu J, Zhao Y 

Received 22 July 2025

Accepted for publication 17 December 2025

Published 15 January 2026 Volume 2026:19 549193

DOI https://doi.org/10.2147/IDR.S549193

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Sandip Patil

Yong Ling,1,* Yangxi Deng,1,* Peipei Zhang,1 Kaixuan Yuan,1 Long Ye,1 Xinqiang Zhang,1 Xiaoli Chen,1 Shanzhao Cui,1 Jie Liu,2 Yunhu Zhao1 

1Department of Clinical Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, People’s Republic of China; 2Department of Reproductive Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Jie Liu, Email liujie@gdph.org.cn Yunhu Zhao, Email zhaoyunhu@gdph.org.cn

Introduction: Streptococcus agalactiae (Group B Streptococcus, GBS) is a Gram-positive opportunistic pathogen and a leading cause of invasive infections in neonates and pregnant women worldwide. Pathogenicity and transmission dynamics are shaped by capsular serotypes, clonal backgrounds, and virulence and resistance determinants, which vary over time and by region. Data from South China remain limited. This study characterized the serotype distribution, sequence types (STs), clonal complexes (CCs), antimicrobial resistance genes, and virulence factors of clinical GBS isolates from Guangzhou.
Methods: GBS-positive clinical isolates collected at Guangdong Provincial People’s Hospital (Guangzhou, China) from 2016 to 2022 were subjected to genomic epidemiology analyses. A total of 72 non-duplicate isolates were included. Multilocus sequence typing (MLST) and whole-genome sequencing (WGS) were used to determine capsular serotypes, sequence types (STs) and clonal complexes (CCs), and to identify antimicrobial resistance genes and virulence determinants, including pilus islands.
Results: Among 72 isolates, serotype III predominated (36.1%), followed by serotype V (25.0%). Isolates were assigned to 22 STs within 7 CCs, with ST19 being most common (15.3%). Resistance gene profiling showed tetM in 61.1% of isolates and ermB in 37.5%. Virulence factor analysis indicated universal presence of lmb, bca, and cpsJ; 97.2% carried the hemolysin gene hlyB. Pilus island genes PI-1 and PI-2a were detected in 73.6% of isolates.
Discussion: GBS circulating in Guangzhou shows a serotype distribution dominated by III and V and a diverse clonal structure with ST19 prominence. The high carriage of tetM and ermB suggests sustained selective pressure for tetracycline and macrolide resistance, while the near-ubiquitous virulence repertoire—including lmb, bca, cpsJ, and hlyB—and frequent PI-1/PI-2a may support colonization and invasiveness. These findings highlight the need for ongoing, region-specific genomic surveillance to track serotype/lineage shifts and resistance trends and to inform prophylaxis, empiric therapy, and future vaccine coverage in South China.

Keywords: Group B Streptococcus, serotype, multilocus sequence typing, resistance gene, virulence factor, whole-genome sequencing